We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
11 hedge funds and large institutions have $937K invested in Atossa Therapeutics in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
211% more capital invested
Capital invested by funds: $301K → $937K (+$636K)
83% more funds holding
Funds holding: 6 → 11 (+5)
Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$740K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$94.7K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$41.4K |
| 4 |
Millennium Management
New York
|
+$29.6K |
| 5 |
Morgan Stanley
New York
|
+$23.7K |
Top Sellers
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$23.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$1K |